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A theoretical four-compartment model to evaluate separate kid-
ney technetium-99m-MAG3 kinetics in humans.
Background. Pharmacokinetic modeling based on compartmen-
talization has provided a valuable tool to assess the clearance
patterns of various glomerular and tubular agents. However, no
models have been proposed thus far that combine vascular data
and imaging data in order to gain a deeper knowledge on renal
pathophysiology, and to obtain more diagnostic information of
clinical relevance. To this aim, we propose a four-pool model for
the evaluation of separate renal function.
Methods. In a group of ten normal volunteers and twenty
patients with various renal diseases, we tested the four-pool model
based on the identification of the two kidneys as two distinct
pools. This approach made it possible to integrate the separate
kidney contributions deriving from in vivo imaging data, and
allows the researcher to quantitate many parameters specific to
each kidney.
Results. The parameters TERR, TERL, MRTR, MRTL, nR, nL,
k3R-1, k3L-1 permit the normal from abnormal states of renal
function to be differentiated, as well as monolateral from bilateral
renal disease to be separated within the abnormal function group.
Conclusions. The proposed approach combines the advantages
of plasma clearance methods with those derived by gamma-
camera imaging, and makes it possible to quantitate the differen-
tial renal function. This feature may be clinically relevant in renal
transplant donors, where full knowledge of renal pathophysiology
could guide the procedure.
In 1955, Sapirstein and coworkers first described a
two-compartment approach for the analysis of the plasma
clearance curve of (unlabeled) creatinine injected as an i.v.
bolus in dogs [1]. Since then, pharmacokinetic modeling
based on compartmental analysis has provided a valuable
tool to assess the clearance patterns of various glomerular
and tubular agents, aimed at gaining both a deeper knowl-
edge of renal pathophysiology and diagnostic information
of clinical relevance [2–9].
In particular, Van Stekelenburg et al experimentally
tested the application of a two-compartment model for
analyzing the radiolabeled hippuran renogram in humans
[3], while a six-compartment model, based on gamma-
camera renography only, was proposed by Wolf, Butter-
mann and Pabst [7]. On the other hand, the seven-com-
partment model proposed by DeGrazia et al, also based on
gamma-camera data from multiple areas of interest, in-
cluded cumulative urinary excretion as well [5]. However,
none of these authors made full use of all of the available
information, which when dealing with tracer kinetics should
also include data on plasma.
In the present study, we propose a four-compartment
model whose basic approach takes into account data from
both vascular sources (direct blood sampling) and in vivo
imaging sources (gamma-camera studies). The renal func-
tion component is then split into two distinct pools, that is,
left kidney and right kidney. Integration of the imaging data
with the plasma curve allows the two kidneys to be identi-
fied as two distinct pools, as well as in cases of perfectly
symmetrical renal function. The proposed four-pool model
was tested in different groups of patients in order to define,
among the multiple kinetic parameters evaluated, those
which provide the most useful information on renal func-
tion in normal and in pathological conditions.
METHODS
Study population
Four groups of subjects were studied: (1) the control
group (N) included 10 healthy volunteers recruited among
staff personnel and specialists in training (7 men and 3
women, mean age 42 6 10 years); (2) group P1 included 6
patients with symmetrical renal damage mostly resulting
from chronic glomerulonephritis (5 men and 1 woman,
mean age 51 6 11 years); (3) group P2 included 8 patients
with unilateral right damage (6 men and 2 women, mean
age 52 6 8 years); (4) group P3 included 6 patients with
unilateral left kidney damage (4 men and 2 women, mean
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age 46 6 10 years). The twenty patients (group P) alto-
gether were classified on the basis of medical history and
the common clinical and laboratory findings including renal
time-activity curves of injected 99mTc-MAG3. Unilateral
damage mostly resulted from the late effect of pyelonephri-
tis due to vesico-ureteral reflux.
Data collection
After adequate hydration, each subject was injected into
an antecubital vein with an i.v. bolus of about 37 MBq
99mTc-MAG3, supplied as an instant-labeling kit formula-
tion (Technescan MAG3; Mallinckrodt Medical BV, Pet-
ten, Holland), while a vein of the contralateral arm was
utilized for blood sampling. For each subject, thirteen 7-ml
blood samples were drawn into standard EDTA-anticoag-
ulated vacuum tubes at 5, 10, 20, 30, 45, 60, 75, 90, 105, 120,
150, 180, 210 minutes. A separate standard for 99mTc-
MAG3 was prepared by dilution in 2000 ml of physiological
saline from duplicate syringe. Three-milliliter plasma sam-
ples obtained from each blood specimen and 3-ml aliquots
of the acqueous standard solution were pipetted into
counting tubes and counted using a multichannel Packard
Autogamma Spectrometer with a 10% window centered on
the 140 keV energy peak of 99mTc. Before injection, each
subject had been positioned supine on the imaging bed of
a large-field-of-view gamma camera (Elscint Apex SP6)
equipped with a low-energy all-purpose collimator, to
acquire posterior views. Dynamic sequences were recorded
starting upon tracer injection with a time resolution of 1
frame/3 seconds (64 3 64 pixels) for the first two minutes
and of 1 frame/15 seconds for the following 28 minutes.
Five regions of interest (ROIs) were selected: the two renal
areas, the two perirenal areas, and the cardiac area (Fig. 1).
The time-activity curves defined over these five ROIs were
normalized by calculating the mean counts per pixel. The
counts recorded on renal ROIs were then corrected for: (1)
background activity in the semilunar ROIs placed around
the lower, outer renal margins; (2) depth of each kidney,
estimated by the formula of Tonnesen et al [10] with a
linear attenuation coefficient for 99mTc radiation in soft
tissues equal to 0.153 cm21 [11]; and (3) blood pool activity
within each kidney. This last correction was performed by
determining the blood pool partition coefficient based on
the heart and each separate kidney curve, as described
previously [12–15]. Using the background-corrected and
blood pool-corrected kidney curves, values for the tracer
accumulation rates in the right (kuR) and left (kuL) kidneys
were then derived (based on the early portion of the
activity-time curves). The rates of irreversible loss of radio-
activity from the right (koR) and left (koL) kidneys were
similarly determined, taking into account the early, mono-
exponential portion of the wash-out phase of the corrected
renal activity curves.
Model
The four-pool model consists of the following compart-
ments: (a) compartment 1, the fast initial distribution pool,
that is, the injection compartment; (b) compartment 2,
which includes unidentified extravascular and extrarenal
spaces; (c) compartment 3L, the left kidney; and (d)
compartment 3R, the right kidney (Fig. 2). Irreversible loss
of radioactivity from the system proceeds only from the
kidneys to urine.
Data analysis
In each subject, the rates of uptake in the right and left
kidneys (kuR and kuL) derived from gamma-camera imag-
ing data were compared with each other. When the differ-
ence between kuR and kuL was greater than 20% of their
mean value ku, that is, when D % (5 ? kuR 2 kuL ?/ku) . 20,
the plasma curve determined by in vitro counting was fitted
to a solution of the system of differential equations of the





The 20% threshold was selected on the basis of preliminary
evaluations showing that the cumulative error possibly
affecting the estimate of kuR and kuL, and consequently
their difference, was always lower than 20% of their mean
value, even in the least favorable conditions.
In this solution based on four exponentials, Y(t) (KBq/
ml/1.73 m2) indicates plasma concentration at time t (min)
normalized to a reference body surface of 1.73 m2, ex-
pressed as % injected dose (ID) (MBq/ml); Ai (% ID/ml/
1.73 m2) is the intercept on the y-axis of the different
Fig. 1. Gamma-camera display showing the region of interest (ROI) of
the heart, kidneys and perirenal regions used as background in a normal
subject (case number 6, group N).
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components of the plasma curve; and li (min
21) represents
the slope of the four components of the curve. In those
cases where D% was # 20, the plasma curve data were
fitted to a solution of the type (Appendix, Eq. A2):




This represents a general solution (based on three expo-
nentials) of the characteristic polynomial for the homoge-
neous linear differential equation when a root l1 of multi-
plicity 2 exists [16–18]; A1, Ai, l1, li have the same meaning
as indicated above. This analysis was performed with a
commercially available program based on subsequent iter-
ations [19], which also provided an approximation of the
variance/covariance matrix of the parameters studied, by
minimizing the sum of squares of nonlinear functions [20].
Kinetic parameters
The parameters that characterize the four-pool model
include: (1) those determined directly from gamma camera
studies without assuming any preassigned model structure,
and (2) those directly quantified by using a combined
integral-differential solution [19–22] based on vascular and
organ data (heart and kidneys). The first group includes:
(a) the fractional transfer rates k3R-1 and k3L-1 (identified as
the rates of accumulation in the right anf left kidney,
previously indicated as kuR and kuL); (b) the fractional
transfer rates k0-3R and k0-3L (identified as the correspond-
ing rates of irreversible tracer loss from kidneys to bladder
k0R and k0L). The second group of kinetic parameters
includes: the volume of the fast initial distribution pool
(V1), the volume of the extravascular pool (V2), and the
volumes of the right and left kidney (V3R and V3L), the
fractional transfer rates between compartments k1-2, k2-1,
k3R-1 and k3L-1. The total tubular excretion rate (TER) and
the tubular excretion rate of each kidney, that is, TERR and
TERL, were also determined (this is a clearance value). In
addition, the mean residence time of the tracer in the
system, MRT (MRT 5 VTot/TER), its permanence time in
compartments 3R and 3L (MRT3R and MRT3L), that is,
the expected interval of time the substance spends in all
passages through these compartments, were also estimated.
Moreover, t1, t2, t3R and t3L were quantified to determine
the expected intervals of time the substance spends in each
passage through compartments 1, 2, 3R and 3L. Finally, we
determined the turnover number, n3R and n3L, of compart-
ments 3R and 3L (ni 5 MRT i/ti), that is, the expected
number of passages of the substance in the same compart-
ments.
Statistical analysis
All data were expressed as mean 6 SD. Multivariate
Hotelling test was performed considering all variables to
compare the group of normal subjects (N, N 5 10) with that
including all patients (P, N 5 20), and to compare group N
Fig. 2. Schematic representation of the four-
compartment model for 99mTc-MAG3. The
compartment 1 (the injection compartment) is
interconnected with the compartment 2 (the
extravascular tissues) and with the
compartments 3R (the right kidney) and 3L
(left kidney). Irreversible loss of radioactivity
from the system proceeds only from the kidneys
to urine.
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with groups P1 (N 5 6), P2 (N 5 8), and P3 (N 5 6).
Univariate analysis of each variable was performed and, in
order to compare N with each patient’s groups, multiple
comparisons using Dunnett’s test were performed. All
computations were carried out using the SAS 610 program
GLM procedure. Probability values lower than 0.05 were
considered statistically significant.
RESULTS
Mean values and ranges of the plasma data (expressed as
percent of the injected dose per liter), determined in all
groups studied are depicted in Figure 3.
Mean values and ranges for the kinetic parameters
determined in all groups studied are listed in Table 1. In the
six patients with symmetrical renal impairment, the mean
value for TER (MAG3) was significantly lower than in
normals (115.8 vs. 306.9 ml/min/1.73 m2, P , 0.05). In these
patients we observed increased mean values for V1 and V2
compared to the normal values (6.18 vs. 4.48 liter/1.73 m2,
and 12.24 vs. 7.96 liter/1.73 m2, respectively). The mean
residence time (MRT) of the tracer in the system was
significantly longer than in normals (192.3 vs. 42.2 min, P ,
0.05), while the mean number of passages in right and left
kidney resulted to be increased with respect to the corre-
sponding normal values (8 vs. 5). In the eight patients with
unilateral right renal damage, we observed significantly
decreased mean values for k3R-1 and k0-3R with respect to
the normal values (P , 0.05), while the k3L-1 and k0-3L
values were not different from the normal values. The
opposite was observed in the six patients with unilateral left
renal damage where, in presence of normal values for k3R-1
and k0-3R, the k3L-1 and k0-3L values were markedly de-
creased. In these patients, we observed increased values for
the distribution spaces V1 and V2 (8.79 vs. 4.48 liter/1.73
m2, and 14.06 vs.7.96 liter/1.73 m2, respectively); the clear-
ance rate in the injured organ was found to be significantly
decreased (43.4 vs.151.0 ml/min/1.73 m2). At the same time,
the permanence time in the injured kidney was markedly
prolonged (12.9 vs. 4.7 min in group P2 and 14.2 vs. 5.4 min
in group P3). Nevertheless, in these patients the number of
passages required for final exit from the system was the
same in both the injured and unaffected kidney, about
twofold more than the normal value (10 vs. 5).
Table 2 summarizes the results of multivariate analysis
for comparing all groups of our population. In particular,
the comparison was carried out between: (a) groups N and
P; (b) between N, P1, P2 and P3; (c) and between P1, P2 and
P3. Figure 4 depicts fitting of the model-estimated param-
eters to the experimental plasma clearance curves observed
in two representative patients, respectively case number 6
(group N) and case number 19 (group P3, with unilateral
left kidney damage).
DISCUSSION
In this work concerning renal dynamics, we implemented
a four compartment model where the deterministic ap-
proach allows a derivation of the kinetic parameters that is
specific to tissues, with the goals of differentiating normal
Fig. 3. Mean values and range of the plasma
data (expressed as percent of the injected dose
per liter) determined in 10 healthy volunteers
(group N), in 6 patients with symmetrical renal
damage (group P1), in 8 patients with
unilateral right damage (group P2), and in 6
patients with unilateral left renal damage
(group P3). Symbols are: (F) Group N; ()
Group P1; (M) Group P2; (X) Group P3.
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from abnormal states of renal function and to achieve
deeper knowledge of renal pathophysiology. In previously
described models both kidneys were assigned to a single
compartment from which any exit of tracer back to plasma
was neglected [3, 5–7]. This is not consistent with the true
renal dynamics. As a matter of fact, when one considers
that in normals about 300 ml of plasma containing 99mTc-
MAG3 reach the tubular cells every minute [23–25], assign-
ing to kidneys a purely non-active transport function, all
tracer should be cleared from plasma in few minutes.
Actually, in normals the mean residence time of the
substance in the system is about 45 minutes [23, 24], and
therefore one should conclude that a significant fraction of
tracer per unit time returns from tubular cells to plasma
prior to its irreversible exit. Recently Stabin et al adopted a
three pool model to assess radiation dosimetry for different
renal agents, including 99mTc-MAG3 in humans, the struc-
ture of which did not exclude the active presence of kidneys
as concerns tracer kinetics, similar to our model [9]. The
model we propose implies partial removal of the substance
at each passage in kidneys, which becomes complete only
after various passages through the central plasma compart-
ment. In fact, irreversible losses from the kidney pools are
the only routes through which the substance is removed
(cleared) from the entire system.
The basic idea of this work is the possibility to fix the
structure of the model in a way that is somewhat specific for
each single patient and, on the other hand, to modify the
type of solution to the system of differential equations
(Appendix). In order to make this point clear, we subdi-
vided the population studied in two sets. The first set
included those subjects in whom a significant difference,
not ascribable to errors, existed between the rates of uptake
kuR and kuL, consistent with a monolateral renal damage.
In this case, the solution is a sum of four exponential terms
(Appendix, Eq. A1). The other set includes normals and
patients with bilateral symmetrical renal damage. In this
case the solution is a sum of three exponential terms,
together with a linear term that takes into account the
presence of a multiple root, caused by a nearly equal rate of
equilibration between plasma and two kidneys (Appendix,
Eq. A2). The latter solution, which allows the compart-
ments 3R and 3L to be “split” (Fig. 2) that otherwise would
be “lumped” into a single pool, has been demonstrated
mathematically in many standard textbooks and papers
[16–18]. The linear term, which is important only at a time
earlier than the time at which the function (t e2l1t) reaches
the maximum (that is, t , 1/l1), in our cases was always
shorter than three minutes. Since the first plasma sample
was taken five minutes after i.v. injection of the radiotracer,
actually the experimental plasma data were fitted to a sum
of three exponential terms, as the contribution of the linear
term was negligible. The structure of the model we propose
Table 1. Mean values and range for the 99mTc-MAG3 parameters determined in healthy volunteers (N), in patients with bilateral (P1), unilateral














21 0.064 6 0.010 0.031 6 0.009a 0.020 6 0.006a 0.065 6 0.006 0.037 6 0.021a
k3L-1 min
21 0.061 6 0.006 0.028 6 0.008a 0.062 6 0.010 0.021 6 0.005a 0.040 6 0.021a
k0-3R min
21 0.21 6 0.03 0.10 6 0.02a 0.08 6 0.02a 0.20 6 0.06 0.13 6 0.06a
k0-3L min
21 0.20 6 0.02 0.09 6 0.04a 0.22 6 0.03 0.09 6 0.05a 0.14 6 0.07a
Four-pool 99mTc-MAG3 model parameters
V1 liter/1.73 m
2 4.48 6 1.08 6.18 6 1.53a 9.00 6 1.06a 8.79 6 1.12a 8.01 6 1.67a
V2 liter/1.73 m
2 7.96 6 1.57 12.24 6 1.81a 14.67 6 1.08a 14.06 6 1.71a 13.79 6 1.78a
V3R liter/1.73 m
2 0.25 6 0.02 0.26 6 0.03 0.24 6 0.03 0.27 6 0.02 0.26 6 0.03
V3L liter/1.73 m
2 0.26 6 0.02 0.27 6 0.03 0.26 6 0.03 0.24 6 0.03 0.26 6 0.03
VTot liter/1.73 m
2 12.95 6 2.46 18.95 6 3.34a 24.17 6 1.85a 23.36 6 2.62a 22.32 6 3.35a
k1-3R min
21 0.91 6 0.21 0.66 6 0.29 0.64 6 0.19 1.92 6 0.31a 1.01 6 0.62
k1-3L min
21 0.85 6 0.23 0.55 6 0.22 1.95 6 0.41 0.68 6 0.20 1.14 6 0.74
k2-1 min
21 0.23 6 0.02 0.29 6 0.02a 0.23 6 0.02 0.23 6 0.02 0.25 6 0.03
k1-2 min
21 0.13 6 0.02 0.14 6 0.01 0.14 6 0.02 0.14 6 0.01 0.14 6 0.01
TER ml/min/1.73 m2 306.9 6 29.7 115.8 6 46.5a 150.4 6 17.4a 152.9 6 38.2a 140.7 6 36.7a
TERR ml/min/1.73 m
2 155.9 6 15.1 58.8 6 18.0a 42.0 6 11.2a 109.5 6 25.8a 68.5 6 35.9a
TERL ml/min/1.73 m
2 151.0 6 20.3 57.0 6 28.9a 108.5 6 12.0a 43.4 6 16.8a 72.3 6 35.8a
MRT min 42.2 6 7.8 192.3 6 107.4a 162.9 6 25.6a 161.5 6 49.5a 171.0 6 64.3a
MRT3R min 4.8 6 0.7 10.9 6 2.8
a 12.9 6 3.7a 5.4 6 1.9 9.8 6 4.5a
MRT3L min 5.0 6 0.6 12.6 6 4.8
a 4.7 6 0.6 14.2 6 4.8a 10.0 6 5.6a
t1 min 2.8 6 0.2 2.9 6 0.2 3.2 6 0.2
a 3.2 6 0.3a 3.1 6 0.2a
t2 min 7.9 6 1.2 7.0 6 0.5 7.1 6 0.9 7.0 6 0.4 7.1 6 0.7
a
t3R min 0.9 6 0.2 1.5 6 0.6
a 1.5 6 0.4a 0.5 6 0.1 1.2 6 0.6
t3L min 1.0 6 0.2 1.8 6 0.8
a 0.5 6 0.1a 1.4 6 0.5 1.2 6 0.7
n3R 5 6 1 8 6 3
a 9 6 2a 12 6 4a 9 6 3a
n3L 5 6 1 8 6 4 10 6 3
a 10 6 2a 9 6 3a
Values are mean 6 SD. Comparison were performed using Dunnett’s test. a P , 0.05
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implies the acquisition of a number of independent param-
eters larger than the number of independent differential
equations based on the tracer concentration in the four
compartments. Thus, in a deterministic approach, plasma
data need to be integrated with additional data that we
derived from gamma-camera studies. This procedure re-
quires careful evaluation of the factors that allow for a
correction of the renal activity curve for background, depth
of kidney, and blood activity. The depth of each kidney was
determined according to the Tonnesen formula [10], which
takes into account weight and height of each subject
studied. This approach is correct when the population
studied does not include obese individuals and subjects
with ectopic kidneys. According to literature [7, 9, 26], we
assumed the fractional transfer rates from plasma to kid-
neys (k3R-1 and k3L-1) to be equal to the rates of uptake
(kuR and kuL), while the fractional excretion rates (k0-3R
and k0-3L) were identified with the rate constants (k0R and
k0L) derived from the nephrogram. When considering the
mean values and ranges for the pharmacokinetic parame-
ters (Table 1), normal subjects exhibited a mean value of
the fast initial distribution volume (V1) equal to 4.48
liter/1.73 m2, in good agreement with the theoretical
plasma volume.
The volume of compartment 1 was much larger in
patients with various renal damage (such as in group P2,
9.00 liter/1.73 m2), as was the volume V2 pertaining to
extravascular extrarenal tissues (such as in group P2, 14.67
liter/1.73 m2). The values for volumes V3R and V3L were
about 0.25 l/1.73 m2 for both kidneys, slightly greater than
the anatomic volume, and this could be the result of an
incorrect assumption made about the kidney as a single
well-mixed compartment. Statistical analysis indicated the
permanence time of the injected tracer in the system
(MRT) as a useful parameter for differentiating normal
and pathological states. However, this same parameter was
unreliable for differentiating various types of renal damage
(Table 1), as were the turnover numbers n3R and n3L not
reliable. On the contrary, parameters k1-3R, k1-3L and k2-1
were unreliable in distinguishing normal from pathological
Fig. 4. 99mTc-MAG3 plasma data in two cases studied: case number 6 (A;
group N) and case number 19 (B; group P3, with unilateral left kidney
damage). The curve represents the fitting of the model-estimated param-
eters to plasma data.
Table 2. Statistical results derived comparing the kinetic parameters in
various groups: N (normal subjects, N 5 10), P (all patients, N 5 20),
P1 (patients with bilateral renal damage, N 5 6), P2 (patients with
unilateral right damage, N 5 8), and P3 (patients with unilateral left





N, P1, P2, P3
(P 5 0.0039)
Hotelling test P1, P2, P3
a
k3R-1 0.0006 0.0001 0.0001
k3L-1 0.0028 0.0001 0.0001
k0-3R 0.0005 0.0001 0.019
k0-3L 0.0064 0.0001 0.013
V1 0.0001 0.0001 0.009
V2 0.0001 0.0001 0.0245
V3R NS NS NS
V3L NS NS NS
VTot 0.0001 0.0001 0.0045
k1-3R NS 0.0001 0.0001




k1-2 0.0499 NS NS
TER 0.0001 0.0001 NS
TERR 0.0001 0.0001 0.0001
TERL 0.0001 0.0001 0.0001
MRT 0.0001 0.0001 NS
MRT3R 0.0015 0.0001 0.0002
MRT3L 0.0096 0.0001 0.0003
t1 0.0069 0.0021 0.0315
t2 0.0315 NS NS
t3R NS 0.0001 0.0004
t3L NS 0.0001 0.0003
n3R 0.0003 0.0039 NS
n3L 0.0007 0.0060 NS
a too few degrees of freedom to perform multivariate analysis
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states, but became useful in identifying different types of
renal damage.
The mean value for the permanence time of 99mTc-
MAG3 in kidneys in our population, MRT3R and MRT3L,
agrees well with the mean value for the mean parenchymal
transit time (MPTT) for 99mTc-MAG3 as computed by
other authors using the nephrogram deconvolution tech-
nique [27]. The values obtained for the fractional transfer
rate from each kidney to plasma (k1-3R and k1-3L) appear to
confirm that a great fraction of tracer returns to plasma
from kidneys prior to its irreversible loss. This fact is in
agreement with the observed mean number of passages of
the tracer in each kidney prior to its irreversible removal,
which results to be about 5 in normals and about 10 in all
patients. The fact that for patients with asymmetrical renal
damage the number of passages increases both in the
injured kidney and in the unaltered kidney may be ex-
plained by a significantly shorter time of each passage in the
unaltered kidney (t3R or t3L) with respect to the contralat-
eral injured organ. This observation is consistent with a
“vicarious” role of the unaffected kidney related to the
impaired function of the contralateral, injured kidney. The
total tubular excretion rate (TER) of 99mTc-MAG3 we
obtained in normal volunteers was equal to 306.9 6 29.7
ml/min/1.73 m2, in good agreement with the corresponding
values obtained by other authors employing a bicompart-
mental approach [23–25, 28].
At present, radiotracer plasma clearance methods [4,
23–25, 28–32] provide an accurate determination of total
renal function, while they cannot provide a separate study
of kidney kinetics. As the present model combines the
implicit advantages of plasma clearance methods with those
derived by gamma-camera methods [35–37], in spite of its
complexity it can be considered a useful tool to achieve
deeper knowledge on the pathophysiology of the renal
system. The clinical utility of the present approach may
arise from the possibility of quantitating the differential
renal function (for example, TERR, TERL, k3R-1, k3L-1,
MRTR, MRTL). In patients with unilateral disease, these
parameters could guide therapy, particularly if the renal
function is severely decreased on one side and a mantained
function is on the contralateral side, where nephrectomy
may be indicated. However, when disease exists in both
kidneys, partial nephrectomy may avoid renal insufficiency.
Furthermore, in renal transplant donors it is crucial to
quantitate the tubular excretion rate of the remaining
kidney. Moreover, the present approach can be used to
assess the degree of improved renal function after angio-
plasty or surgery for renovascular hypertension.
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APPENDIX
In an attempt to define and estimate the kinetic parameters of our
four-pool model, we adopted a procedure that combines the sums of
exponentials approach with the direct model solution approach [19, 21,
22].
When D % . 20, the solution of the system of differential equations is





where Yj (t) represents 99mTc-MAG3 concentration (% ID/ml/1.73 m
2) in
pool j (such as, plasma pool) at time t (min), Aji (% ID/ml/1.73 m
2), and
li (min
21) represents the exponential function coefficients and exponents.
In the cases where D % # 20, since a root l1 of multiplicity 2 of
characteristic polynomial is present, the solution becomes




The direct model solution approach is derived from a set of differential
equations based on linear comparmental system.
If qi(t) represents the quantity of substance in pool i at time t, and Y(tr)
represents the plasma data at time tr, the following equations are derived
directly from the model:
dq1~t!/dt 5 2~k221 1 k3L21 1 k3R21!q1~t! 1 k122q2~t!
1 k123Lq3L~t! 1 k123Rq3R~t! (Eq. A3)
dq2~t!/dt 5 1k221q1~t! 2 k122q2~t! (Eq. A4)
dq3L~t!/dt 5 1k3L21q1~t! 2 ~k123L 1 k023L!q3L~t! (Eq. A5)
dq3R~t!/dt 5 1k3R21q1~t! 2 ~k123R 1 k023R!q3R~t! (Eq. A6)
Y ~tr! 5 q1~tr!/V1
where V1 is the initial distribution plasma volume and r 5 1. . . . . .N
samples of plasma at various times.










qj~t! dt 1 qi~0!
(Eq. A7)





If the data are measures of the qj (t) and are fitted to sum of exponentials














e2akt dt 1 qi~0! (Eq. A8)
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or we may write, in the case of equation A2

















e2akt dt] 1 qi~0! (Eq. A9)
Equations A7, A8 and A9 lend themselves directly to a solution. In
particular, this procedure requires the data to be fitted first to equation A1
or A2. Since the linear term is important only for t , 1/l1 (that is, 3 min),
actually the experimental data were fitted to a function of type:




Thus, initial estimates of the Ajk and ak are required. Then, the calculated
qi (t) are fitted to the experimental data. This procedure is repeated
iteratively until the values of the variable parameters are adjusted until a
least square fit of the data are obtained by using an algorithm for
minimizing the nonlinear function [20].
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